Storia in 2 fonti

Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit

Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses.

Raccontata da

thehindubusinessline.com

economictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo1 g fa

Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit

Neuland Laboratories reported 975% YoY profit surge to Rs 147.4 crore in Q1 FY27, with total income rising 116.3%. EBITDA margin expansion and sustained capex investments signal confidence in scaling commercial product lines and long-term customer partnerships.

originale

thehindubusinessline.com1 g fa

Neuland Laboratories shares jump over 10% to record high after Q1FY27 results

Neuland Q1FY27 PAT ₹147.36 crore yoy surge drove 10.2% stock rally; board approved ₹39.8 crore capacity expansion. Pharma manufacturing scaling amid deepening customer capability engagement signals vendor consolidation and improved contract retention in specialty pharma.

Timeline cronologica

giovedì 6 agosto 2026·thehindubusinessline.com
Neuland Laboratories shares jump over 10% to record high after Q1FY27 results
Neuland Laboratories shares surge over 10% to record high after strong Q1FY27 results and announced manufacturing expansion.
giovedì 6 agosto 2026·economictimes.indiatimes.com
Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit
Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while…